Myalgia

·MeSH: Myalgia

19 drugs in development·16 companies·1 clinical trial

Drug Pipeline by Phase

Approved(3)

Drug	Company
Cymbalta®	ELI LILLY & Co (LLY)
duloxetine	Inventiva S.A. (IVA)
Refining GouPi Cream	China Health Industries Holdings, Inc. (CHHE)

Phase 3(4)

Drug	Company
AXS-14	Axsome Therapeutics, Inc. (AXSM)
Erenumab	UNITED THERAPEUTICS Corp (UTHR)
Erenumab-Aooe	UNITED THERAPEUTICS Corp (UTHR)
imc-1	Dogwood Therapeutics, Inc. (DWTX)

Phase 2(2)

Drug	Company
nyx-2925	Aptinyx Inc. (APTX)
rozanolixizumab	GT Biopharma, Inc. (GTBP)

Phase 1(1)

Drug	Company
sp-104	SCILEX HOLDING CO (SCLX)

Preclinical(4)

Drug	Company
feldetrex	PREMIER BIOMEDICAL INC (BIEI)
prtt-200	PROTECT PHARMACEUTICAL CORP (PRTT)
SP-26	Silo Pharma, Inc. (SILO)
stat-202	Statera Biopharma, Inc. (CBLI)

N/A(1)

Drug	Company
Crisugabalin	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 4(4)

Drug	Company
Pregabalin	ENANTA PHARMACEUTICALS INC (ENTA)
sarilumab	Sanofi (SNY)
Sarilumab	Sanofi (SNY)
secukinumab s.c	Novartis AG (NVS)

BioSniper tracks 19 drugs in development for Myalgia across 16 companies.

There are 1 clinical trial targeting Myalgia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.